Monthly Archives: March 2020

Runda Medical (603108) 2019 First Quarterly Report Review: Pure Endogenous Faster Growing Cash Flow Continues to Improve Event: The company released a quarterly report and achieved revenue of 15 in 19Q1. 3.1 billion (+18. 2%), deduct non-attributed net profit 0. 7 billion (+19. 1%); operating net cash flow of 0. 31 billion U.S. dollars, more… Read Article →

Hesteel (000709): Product structure continues to be high-end, 2Q performance is expected to improve sequentially 2018 first quarter results slightly exceeded expectations. HBIS announced 2018 and 2019 first quarter results: 2018 company operating income of 1,209. 600 million, an increase of 11% in ten years; net profit attributable to mothers 36. 2.6 billion, an increase… Read Article →

Experts on the daily limit of pesticide stocks: monitor the possible migration of desert pollutants into the region For stocks, please read Jin Qilin analyst research report, authoritative, professional, timely, and comprehensive, to help you tap potential potential opportunities!   Experts of the Chinese Academy of Agricultural Sciences believe that although a small number of deserts… Read Article →

China Life Insurance (601628) 2019 Third Quarterly Report Review: High Long-Term Performance Increase Has Been Concerned Matters: China Life announced the third quarter report of 2019. The reported baseline realized net profit attributable to mothers was 577 million, +190. 4%, net profit of non-attributed mothers 5.26 million yuan, +162 for ten years. 4%. At the… Read Article →

Hengrui Medicine (600276) 2019 Interim Report Review: Innovation-Driven Performance Accelerates PD-1 Indications, Leads Domestically Event: The company released its 2019 Interim Report and achieved revenue of 100 in 19H1. 26 trillion, ten years +29. 19%; net profit attributable to mother 24. 12 trillion, +26 a year. 32%; net profit not deducted to mother 22. 89… Read Article →

Mei Nian Health (002044) investment value analysis report It is expected that the company will benefit from the competition barriers under the dual advantages of encouraging social medical policy guidance and scale brands.Participating in the change control model in 2018-2021 will accelerate the realization of performance.In 2018, the company introduced a series of minimum and… Read Article →

Shuijingfang (600779): Accelerated growth in revenue and performance in 19Q4 is expected to be related to the advance of the Spring Festival and a low base In the fourth and fourth quarters, both revenue and performance accelerated, mainly due to the advance of the Spring Festival and the low base effect. The company released the… Read Article →

Shandong Luqiao (000498) 2018 Annual Report Commentary: Profit Recovery Continues, Tiefa Fund Shares Help Expand Railway Business Event: Shandong Luqiao released the 2018 annual report, and the company achieved operating income of 147 in 2018. 700 million, a year-on-year increase of +19. 3%, realizing net profit attributable to mother 6. 600 million, a year-on-year increase… Read Article →

Chihong Zinc and Germanium (600497): Non-current asset disposal results in a significant increase in performance Non-current assets disposal results in a significant decrease in performance According to the company’s annual report, the company achieved operating income of 189 in 2018.51 ppm, a 10-year increase2.6%; net profit attributable to mother 6.23 ppm, a decline of 46… Read Article →

Scroll To Top